glp-1 and suicidal ideation The Therapeutic Goods Administration (TGA) has released a new safety alert for glucagon-like peptide-1 medications. The TGA said it had received 72 reports of ideation, as well as about a dozen GLP-1 diabetes drugs not linked

Important Risks and Side Effects Dialysis patients should be especially cautious about side effects

Support & Care Breakdown Live Chat Human/AI The in-portal chat uses AI to handle basic questions and routes you to a human agent when it cant answer

[ref] Methyl groups : The methylation cycle plays a role in breaking down monoamine neurotransmitters, including histamine

One key change was adding a fatty acid molecule, which helps the drug to be released slowly

But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year

It targets your brains functions that control appetite and food intake